| Literature DB >> 33380581 |
Yudai Shibayama1, Shohei Dobashi2, Takaaki Arisawa3, Tamotsu Fukuoka3, Katsuhiro Koyama4.
Abstract
Molecular hydrogen has been suggested to have a cytoprotective effect on the whole body and to enhance exercise performances. However, the effect of hydrogen-rich gas mixture (HG) inhalation on physiological responses has been poorly investigated. We examined the impact of acute HG inhalation on subsequent oxidative stress, muscle damage, and exercise performances during the recovery period after a strenuous exercise. This is a two-trial, double-blind, crossover, repeated measures study. Eight physically active male volunteers inhaled HG (estimated fraction of inspired oxygen and hydrogen were 21.57 and 4.08% at most, respectively) or normal gas (placebo, ambient air 400 m above sea level) during a 60-minute recovery phase after oxidative stress-inducing exercise) completion comprising 30-minute treadmill running at an intensity corresponding to 75% of maximal oxygen uptake and squat jumps (5 sets × 10 repetitions). Before oxidative stress-inducing exercise and 10 minutes after the post-exercise gas inhalation, blood and urine samples were obtained and exercise performances (jumping ability; pedaling power output; muscle strength) were evaluated. Post-exercise HG inhalation attenuated the increase in urinary 8-hydroxydeoxyguanosine excretion rate (P < 0.05), a DNA oxidation marker, and the reduction in the countermovement jump height (P < 0.05), compared with Placebo inhalation. Other exercise performances and blood oxidative stress and muscle damage markers did not differ between HG and Placebo inhalation. Moreover, the increase in urinary 8-hydroxydeoxyguanosine excretion rate was significantly associated with countermovement jump performance reduction (r = -0.78, P < 0.01). These findings suggested that HG inhalation during post-exercise recovery period might improve exercise performance via reducing systemic oxidative damage. The study was approved by the Human Research Ethics Committee of the University of Yamanashi (approval No. H29-006) on June 28, 2017.Entities:
Keywords: 8-hydroxydeoxyguanosine; endurance running; inhalation; molecular hydrogen; muscle fatigue; oxidative stress; sprint cycling; squat jumps
Year: 2020 PMID: 33380581 PMCID: PMC8092152 DOI: 10.4103/2045-9912.304222
Source DB: PubMed Journal: Med Gas Res ISSN: 2045-9912
Physiological characteristics in the eight healthy male participants
| Variables | Data |
|---|---|
| Age (yr) | 20.9±0.3 |
| Height (cm) | 171.8±1.6 |
| Weight (kg) | 61.6±1.5 |
| VO2max (mL/kg per min) | 53.7±2.9 |
| v75%VO2max (km/h) | 12.7±0.5 |
Note: Values are mean ± standard error. v75%VO2max: Treadmill speed corresponding to 75% of VO2max; VO2max: maximal oxygen uptake.
Experimental gas composition
| Placebo | HG | |
|---|---|---|
| Oxygen (%) | 20.9 | 32.0 |
| Hydrogen (%) | 0.00005 | 68.0 |
| Nitrogen + carbon dioxide (%) | 78.03 | 0.0001 |
Note: HG: molecular hydrogen-rich gas mixture; Placebo: normal gas.
Oxidative stress and muscle damage responses of eight healthy males at Pre- and Post-exercise performance test
| Pre-test | Post-test | Two-way analysis of variance | |||
|---|---|---|---|---|---|
| Gas × Time | Gas | Time | |||
| Serum d-ROMs (Caratelli unit) | n.s. | n.s. | n.s. | ||
| Placebo | 187.4±11.3 | 196.8±12.1 | |||
| HG | 187.5±14.9 | 196.4±13.4 | |||
| Serum BAP (^M) | n.s. | n.s. | n.s. | ||
| Placebo | 2177.8±173.1 | 2164.9±177.7 | |||
| HG | 2123.8±105.1 | 2229.6±185.3 | |||
| Serum BAP/d-ROMs (A.U.) | n.s. | n.s. | n.s. | ||
| Placebo | 12.0±1.2 | 11.4±1.3 | |||
| HG | 12.1±1.2 | 12.3±1.8 | |||
| Urinary 8-hydroxydeoxyguanosine excretion rate (ng/kg per hour) | n.s. | n.s. | |||
| Placebo | 4.0±1.0 | 18.9±2.3 | |||
| HG | 7.7±1.6 | 22.8±2.0 | |||
| Serum creatine kinas activity (U/L) | n.s. | n.s. | |||
| Placebo | 125.1±4.8 | 196.3±34.9 | |||
| HG | 117.0±5.2 | 216.0±18.0 | |||
| Serum lactate dehydrogenase activity (U/L) | n.s. | n.s. | |||
| Placebo | 186.9±10.7 | 215.1±11.1 | |||
| HG | 183.4±8.8 | 221.0±11.9 | |||
| Number of white blood cells (cells/mL) | n.s. | n.s. | |||
| Placebo | 6002.5±697.5 | 8737.5±1172.1 | |||
| HG | 5665.0±525.5 | 7536.3±643.2 | |||
Note: Values are mean ± standard error, and were analyzed by two-way repeated measures analysis of variance. A.U.: Arbitrary unit; BAP: biological antioxidant potential; BAP/d-ROMs: systemic total antioxidant capacity; d-ROMs: diacron reactive oxygen metabolites; HG: molecular hydrogen-rich gas mixture; n.s.: not significant; Placebo: normal gas; Post: before 2nd P-test; Pre: before 1st exercise performance test (P-test).
Pre- and Post-exercise performances of eight healthy males
| Pre | Post | Two-way analysis of variance | |||
|---|---|---|---|---|---|
| Gas × Time | Gas | Time | |||
| - | - | ||||
| Placebo | 50.7±1.4 | 47.5±1.7* | |||
| HG | 49.9±1.5 | 49.1±1.7 | |||
| n.s. | n.s. | n.s. | |||
| Placebo | 268.3±22.6 | 249.4±13.4 | |||
| HG | 273.6±19.0 | 256.1±14.5 | |||
| Mean power output (W) | n.s. | n.s. | n.s. | ||
| Placebo | 673.4±28.4 | 663.1±36.9 | |||
| HG | 672.0±29.0 | 678.8±25.5 | |||
| Peak power output (W) | n.s. | n.s. | n.s. | ||
| Placebo | 732.6±29.7 | 719.7±36.9 | |||
| HG | 727.7±30.0 | 736.9±27.2 | |||
| Mean power output (W) | n.s. | n.s. | n.s. | ||
| Placebo | 574.1±21.5 | 576.1±28.3 | |||
| HG | 581.1±27.1 | 573.4±26.9 | |||
| Peak power output (W) | n.s. | n.s. | |||
| Placebo | 712.2±30.7 | 690.8±30.2 | |||
| HG | 707.4±27.4 | 693.3±26.7 | |||
Note: Values are mean ± standard error, and were analyzed by two-way repeated measures analysis of variance. *P < 0.05, vs. Pre. HG: Molecular hydrogen-rich gas mixture; n.s.: not significant; Placebo: normal gas; Pre: before 1st exercise performance test (P-test); Post: before 2nd P-test.